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Brown fat is specialized for energy expenditure,
a process that is principally controlled by the tran-
scriptional coactivator PGC-1a. Here, we describe
a molecular network important for PGC-1a function
and brown fat metabolism. We find that twist-1 is
selectively expressed in adipose tissue, interacts
with PGC-1a, and is recruited to the promoters of
PGC-1a’s target genes to suppress mitochondrial
metabolism and uncoupling. In vivo, transgenic
mice expressing twist-1 in the adipose tissue are
prone to high-fat-diet-induced obesity, whereas
twist-1 heterozygous knockout mice are obesity
resistant. These phenotypes are attributed to their
altered mitochondrial metabolism in the brown fat.
Interestingly, the nuclear receptor PPARd not only
mediates the actions of PGC-1a but also regulates
twist-1 expression, suggesting a negative-feedback
regulatory mechanism. These findings reveal an
unexpected physiological role for twist-1 in themain-
tenance of energy homeostasis and have important
implications for understanding metabolic control
and metabolic diseases.
INTRODUCTION
Obesity and its associated metabolic diseases are caused by
a long-term imbalance between energy intake and energy
expenditure. Adipose tissues serve as major sites for the control
of energy balance. They are present in two functionally distinct
types: white fat and brown fat. White fat stores excess energy
in the form of triglycerides and releases them in times of energy
need. By contrast, brown fat is specialized for energy expendi-
ture by dissipating energy as heat, a process termed as adaptive
thermogenesis (Cannon and Nedergaard, 2004; Lowell and
Spiegelman, 2000). The unique metabolic property of brown fat
is due to its high mitochondrial density and fuel oxidation
capacity, and to its exclusive expression of uncoupling protein-1
(UCP1) in the inner mitochondrial membrane, which uncouplesthe mitochondrial proton gradient from ATP production. Given
the fundamental importance of adipose tissues in the mainte-
nance of systematic energy homeostasis, their functions must
be tightly regulated.
As a heat-generating organ, brown fat plays a key part in the
regulation of energy balance and obesity, as evidenced in rodent
studies. For instance, either ablation of brown fat through
expression of a toxic transgene or knockout of UCP1 leads to
high susceptibility to diet-induced obesity (Kontani et al., 2005;
Lowell et al., 1993), whereas increase of UCP1 expression
protects animals against diet-induced obesity (Kopecky et al.,
1995). However, human adults, unlike rodents and human
neonates, do not possess discrete brown fat depots, and brown
fat cells are dispersed within white fat, casting doubt on whether
human brown fat cells are of physiological and/or pharmacolog-
ical significance. On the other hand, it has long been observed
that brown fat cells in humans have a remarkable capacity for
recruitment and expansion in the presence of high sympathetic
input or prolonged cold exposure (Garruti and Ricquier, 1992;
Huttunen et al., 1981; Lean et al., 1986). Moreover, recent tracer
studies coupled with imaging technology demonstrated a much
wider anatomic distribution of brown fat than was previously
thought in several regions of the human body in normal individ-
uals (reviewed in Nedergaard et al., 2007). Both cell culture
and animal model studies also suggest that white fat cells
show plasticity and can be induced to acquire brown fat features
(Seale et al., 2007; Tiraby and Langin, 2003). Finally, only a small
increase of brown fat activity appears to be sufficient to coun-
teract obesity, as has been seen in mice that contain ectopic
deposition of brown adipocytes in the skeletal muscle (Almind
et al., 2007) or in mice that express UCP1 in the white fat at
a very low level (Kopecky et al., 1995). These observations revive
the idea that brown fat remains an attractive therapeutic target
tissue for obesity and associated diseases. Clearly, there is
a strong need to understand the molecular basis underlying
brown fat metabolism.
A central regulator in brown fat thermogenesis is the transcrip-
tional coactivator PGC-1a (reviewed in Lin et al., 2005). PGC-1a
is predominantly expressed in the brown fat, and its expression
is highly influenced by nutritional and environmental cues. Both
overexpression and loss-of-function studies demonstrate that
PGC-1a regulates the entire program of thermogenesisCell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc. 73
(Lin et al., 2005; Uldry et al., 2006). As might be expected,
regulatory mechanisms must be in place to fine-tune PGC-1a
function. Studies have suggested that PGC-1a activity is posi-
tively regulated by several transcriptional regulators; these
include Src-1, Sirt1, LRP130, and PRDM16 (Cooper et al.,
2006; Lagouge et al., 2006; Picard et al., 2002; Puigserver
et al., 1999; Rodgers et al., 2005; Seale et al., 2007). Conversely,
PGC-1a mRNA expression in the brown fat is inhibited by Rb
protein and the orphan nuclear receptor SHP (Scime et al.,
2005; Wang et al., 2005). Two factors, GCN5 and p160MBP,
have been shown to suppress PGC-1a activity (Fan et al.,
2004; Lerin et al., 2006); however, their functional relevance in
brown fat metabolism is unknown. Interestingly, among all of
the PGC-1a regulators identified so far, only PRDM16 displays
a brown fat-selective expression pattern, with others being ubiq-
uitously expressed in many tissues. Furthermore, the in vivo
requirements for most of these factors in brown fat metabolism
have not been addressed. Hence, despite these progresses,
physiological regulators for PGC-1a in the brown fat largely
remain to be identified. In particular, it is completely unclear
how PGC-1a function is negatively modulated posttranscription-
ally in the brown fat.
As a transcriptional coactivator, PGC-1a must dock to
transcriptional factors to exert its biological function. In vitro,
PGC-1a is found to interact with many transcriptional factors
(Lin et al., 2005). Among them are nuclear receptor peroxisome
proliferator-activated receptors (PPARs) and estrogen-related
receptors (ERRs), which themselves have been implicated in
oxidative metabolism. However, the relative importance of these
factors in brown fat metabolism is elusive. In the absence of
PPARg or ERRa, UCP1 can still be induced (Seale et al., 2007;
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Figure 1. Twist-1 Is Selectively Expressed
in theAdipose Tissue but DoesNot Regulate
Adipogenic Differentiation
(A) Twist-1 expression in different tissues of adult
C57BL6 mice (n = 4). In this and all other figures,
gene expression data were normalized with
U36B4 levels. Error bars represent standard error
of the mean.
(B) Twist-1 expression before and after brown fat
adipogenic differentiation in culture. Error bars
represent standard error of the mean.
(C) Oil red O staining of differentiated brown fat
adipocytes overexpressing twist-1.
Villena et al., 2007), indicating that neither
PPARg nor ERRa is essential for UCP1
expression. Thus, the identity of the
downstream major transcriptional factors
that mediate PGC-1a function in the
brown fat remains to be determined.
In this manuscript, we identified a
transcriptional network present in the
brown fat that regulates and coordinates
with PGC-1a. Twist-1, a helix-loop-helix-
containing transcriptional regulator, is
expressed in embryonic stages and is
important for early development (Chen and Behringer, 1995),
antiapoptosis (Sosic et al., 2003), and osteoblast differentiation
(Bialek et al., 2004). Recent work also shows that twist-1 is
overexpressed in many human cancers and cancer cell lines,
thereby driving tumor invasion and metastasis (Ansieau et al.,
2008; Ma et al., 2007; Yang et al., 2004). Surprisingly, we find
that twist-1 is mainly present in the adipose tissue and acts as
a negative-feedback regulator of PGC-1a/PPARd-mediated
brown fat metabolism. Our studies provide molecular insights
into brown fat metabolism and have important implications in
obesity and its associated metabolic diseases.
RESULTS
Twist-1 Is Selectively Expressed in the Adipose Tissue
but Does Not Regulate Adipogenesis
To understand tissue-specific molecular components and path-
ways that control energymetabolism, we queried the human and
mouse gene expression databases (Su et al., 2002) to search for
transcriptional regulators that are preferentially expressed in the
adipose tissue. One factor identified from these databases is
twist-1. As shown in Figure 1A, quantitative PCR analyses
confirmed that twist-1 was most abundantly expressed in the
brown fat and white fat of adult mice, typically at a level more
than10-fold higher than in other tissues. A similar expression
profile was obtained with northern blot analyses (data not
shown). Moreover, the twist-1 level was increased in mature
adipocytes compared to preadipocytes in culture (Figure 1B).
These data together led us to test whether twist-1 is involved
in the adipogenesis of brown fat or white fat. To this end,
we infected a brown fat preadipocyte cell line we generated74 Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc.
(see below) with twist-1 expression retrovirus. Cells with stable
viral integration were pooled and then induced to adipogenic
differentiation. Retroviral twist-1 expressed at a level of 5-fold
relative to its endogenous level in mature adipocytes, which cor-
responded to a 10-fold difference in preadipocytes (Figure 1C).
Oil-red O staining revealed no obvious difference in lipid accu-
mulation between cells overexpressing twist-1 and cells with
vector alone (Figure 1C). Similarly, retroviral overexpression of
twist-1 in the white fat preadipocyte 3T3-L1 cells had no signifi-
cant effect on adipogenic differentiation (Figure S1 available
online). Taken together, we found that the transcriptional regu-
lator twist-1 is selectively expressed in the adipose tissue and,
interestingly, that it does not participate in adipogenesis.
Twist-1 Inhibits the Transcriptional Activity of PGC-1a
through Their Direct Interaction
Given the lack of effect of twist-1 on adipogenesis, we consid-
eredwhether twist-1 regulates energy dissipation, a predominant
metabolic pathway in the brown fat controlled by PGC-1a. To
begin testing this hypothesis, we examined whether twist-1
modulates the transcriptional activity of PGC-1a in cos-7 cells.
Full-length PGC-1a fused with the DNA-binding domain (DBD)
of yeast Gal4 had a robust transcription activity when assayed
in a luciferase reporter driven by the Gal-UAS sequence (Puig-
server et al., 1999). In the presence of twist-1, the activity of
Gal4-PGC-1a was strongly inhibited (Figure 2A), whereas the
activity of Gal4 DBD alone was unaffected. Twist-1 also inhibited
PGC-1a-mediated activation of peroxisome proliferator-acti-
vated receptors (PPARs) (Figure 2B and data not shown). On
the other hand, twist-1 had no effect on the basal or agonist-
stimulated activity of PPARs (Figure 2C); this was due to the
fact that, in cos-7 cells, there is little endogenous PGC-1a and
the agonists-mediated activation of PPARs occurs presumably
through recruitment of a different set of coactivators rather
than PGC-1a. Thus, twist-1 is a specific inhibitor of PGC-1a.
We examined the possibility that coexpression of twist-1
may cause a decrease in the PGC-1a protein level and/or pertur-
bation of its nuclear localization. Flag-tagged twist-1 and HA-
tagged PGC-1a were coexpressed in HEK 293 cells. Contrary
to what is expected, PGC-1a protein was surprisingly stabilized
in the presence of twist-1 (Figure S2A). Consistent with this
observation, twist-1 blocked the ubiquitination of PGC-1a
(data not shown). Immunofluorescence staining further demon-
strates that expression of twist-1 stabilized PGC-1a and did
not perturb its cellular localization pattern (Figure S2B).
We next determined whether twist-1 and PGC-1a physically
associate. An interaction between these two proteins was readily
detected (Figures 2D and 2E). There was also aweak association
between twist-1 and PGC-1b (Figure 2E). However, interactions
between twist-1 and other coactivators, such as p300 or src
members, were almost undetectable (Figure 2D). We found
that the first N-terminal 30 amino acids of twist-1, a small region
that is conserved in the closely related member twist-2, was
required for its interaction with PGC-1a, whereas the conserved
C terminus was dispensable (Figure 2F). Not surprisingly, twist-2
also interacted with PGC-1a and suppressed its transcriptional
activity (Figure S3), but twist-2 expression in the brown fat and
white fat is extremely low. The C-terminal half (aa 350 throughthe end) of PGC-1a mediated its interaction with twist-1
(Figure 2G). Importantly, deletion of this C-terminal half substan-
tially increased its transcriptional activity compared to the full-
length form (Figure 2H, left panel) and abolished twist-1’s
inhibitory effects (Figure 2H, right panel). These data demon-
strate that inhibition of PGC-1a activity by twist-1 depends on
the interaction between PGC-1a and twist-1, despite the fact
that this interaction renders PGC-1a protein more stable.
Twist-1 Specifically Suppresses PGC-1a-Mediated
Mitochondrial Oxidative Metabolism and Uncoupling
We asked whether the inhibition of PGC-1a transcriptional
activity by twist-1 is of functional significance. We first ad-
dressed this question in differentiated C2C12 myotubules; these
cells express little endogenous levels of PGC-1a and twist-1,
therefore providing us a system by which to directly and
unambiguously assess their functional interaction by ectopic
expression. As shown by others and in Figure 3A, adenovirus
expression of PGC-1a in themyotubules induced the expression
of an array of genes involved in mitochondrial oxidative metabo-
lism. Coexpression of twist-1 strongly negated the induction of
these PGC-1a target genes (Figure 3A). Yet, twist-1 had little
effect on the basal levels of these genes when PGC-1a was
not present, nor did it have any effects on non-PGC-1a target
genes, such as those involved in fatty acid synthesis. Moreover,
the PGC-1a-stimulated oxygen consumption and fatty acid
oxidation was reduced by coexpression of twist-1, whereas
basal oxygen consumption and fatty acid oxidation was unaf-
fected (Figure S4). Twist-1 also inhibited PGC-1b-induced gene
expression (Figure S5) but was less robust, consistent with the
weak physical association between twist-1 and PGC-1b. Taken
together, these results indicate that twist-1 specifically targets
PGC-1 to modulate oxidative metabolism.
Twist-1 belongs to a class of transcriptional regulators that
contain a basic helix-loop-helix domain. The basic region recog-
nizes a consensus DNA element called E-box. To rule out the
possibility that the inhibitory effects of twist-1 require its binding
to potential E-boxes on the promoters of PGC-1a target genes,
we generated a twist-1 point mutation in residue E121,
a conserved residue located in the basic region important for
DNA binding (Atchley and Fitch, 1997). Twist-1 binds to the
E-box of the promoter of the GLI-Krupped family member GLI1
and activates its expression (Villavicencio et al., 2002). The
E121K mutant lost its ability to induce GLI1 expression
(Figure S6A). However, thismutant was still capable of suppress-
ing both the activity of PGC-1a in reporter assays and the
expression of PGC-1a target genes (Figures S6B and S6C).
These results demonstrate that suppression of PGC-1a target
gene expression by twist-1 does not rely on its DNA-binding
activity. This is consistent with the data showing that twist-1
has a widespread inhibitory effect on every PGC-1a target
gene we examined (Figure 3A and data not shown).
Both twist-1 and PGC-1a are mainly expressed in brown fat.
To investigate the functional role of twist-1 in a more physiolog-
ical setting, we generated an immortalized preadipocyte brown
fat cell line (df/f) from newborn mice in which the PPARd alleles
are floxed by the loxp sites. After differentiation, the df/f cells
exhibited the characteristics of brown fat, including robustCell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc. 75
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Figure 2. Twist-1 Interacts with PGC-1a and Suppresses Its Transcriptional Activity
(A) Dose-dependent inhibition of the transcriptional activity of Gal4-PGC-1a by twist-1. Error bars represent standard error of the mean.
(B and C) Twist-1 inhibits PGC-1a-mediated, but not agonist-mediated, activation of PPARs. PPARd or PPARg, 20 ng; PGC-1a, 20 ng; twist-1, 20 ng. Error bars
represent standard error of the mean.
(D and E) Interactions of twist-1 with coactivators.
(F) PGC-1a interacts with the N terminus of twist-1.
(G) Twist-1 interacts with the C-terminal half of PGC-1a.
(H) Suppression of PGC-1a activity by twist-1 requires their interaction. Left panel, the transcriptional activity of Gal4-PGC-1a fusion constructs wasmeasured in
the absence of twist-1. Right panel, the fold of transcriptional activity in the presence of twist-1 relative to the activity in the absence of twist-1 for Gal4-PGC-1a
fusion constructs was measured. Error bars represent standard error of the mean.76 Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc.
induction of PGC-1a and UCP1 gene expression (Figures S7A
and S7B). We tested whether twist-1 and PGC-1a associate at
endogenous levels in brown fat cells. Because of the poor quality
of the commercially available twist-1 antibody, we stably
expressed HA-tagged twist-1 in df/f cells at a level that
was 1.5-fold of its endogenous level. As shown in Figure 3B,
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Figure 3. Twist-1 Regulates PGC-1a-Mediated Mitochondrial Oxidative Metabolism and Uncoupling
(A) Differentiated C2C12 muscle cells infected with PGC-1a and twist-1 adenovirus.
(B) Twist-1 and PGC-1a interact at physiological levels in brown fat adipocytes.
(C) Brown fat preadipocytes expressing a lentivirus twist-1 RNAi construct or control construct were infected with PGC-1a RNAi or control adenovirus during
differentiation.
(D) Gene expression in differentiated brown fat adipocytes infected with twist-1 knockdown adenovirus.
(E) Mitochondrial DNA content indicated by the level of the mitochondrial genome-encoded CoxII gene.
(F) Left, representative electron microscopy micrographs from differentiated brown fat adipocytes. Right, quantification of mitochondrial density from
13 micrographs. M, mitochondria.
(G) Gene expression in differentiated brown fat adipocytes infected with adenovirus expressing twist-1, PGC-1a, or both.
Error bars represent standard error of the mean in all panels.Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc. 77
PGC-1a antibody, but not control IgG, coimmunoprecipitated
HA-twist-1 from nuclear extracts of differentiated brown fat cells,
suggesting that an interaction between twist-1 and PGC-1a
occurs at physiological levels in vivo.
To test the functional requirement of endogenous twist-1 in the
brown fat cells, we used lentivirus to stably express shRNA
against twist-1 in brown fat preadipocytes. After differentiation
into mature adipocytes, we analyzed the expression of PGC-1a
target genes. Stable knockdown of twist-1 led to a systematic
increased expression of PGC-1a target genes, including UCP1
(Figures 3C and S8), whereas simultaneous knockdown of
PGC-1a by RNAi adenovirus largely eliminated these effects
(Figure 3C). Similar results were obtained when twist-1 was
acutely knocked down with RNAi adenovirus in differentiated
brown fat cells (Figure 3D), further suggesting that the observed
effects of twist-1 are unrelated to adipogenesis. Moreover,
depletion of twist-1 increased mitochondrial biogenesis, as
judged by mitochondrial DNA content and electron microscopy
(Figures 3E and 3F). Conversely, overexpression of twist-1
suppressed the expression of PGC-1a target genes (Figure 3G)
and mitochondrial biogenesis (Figure S9). These results demon-
strate an important role of endogenous twist-1 in the regulation
of mitochondrial oxidative metabolism in brown fat cells, most
likely through negative modulation of endogenous PGC-1a
function.
Transgenic Expression of Twist-1 in the Adipose Tissue
Suppresses Brown Fat Metabolism
To investigate whether the in vitro-identified regulatory role of
twist-1 is relevant to in vivo fat metabolism, we generated
twist-1 transgenic mice, driven by the aP2 promoter. The trans-
gene was expressed at 2.5-fold its endogenous level
(Figure 4A). Under normal chow diet, there was no difference
in body weight between the transgenic mice and control litter-
mates. However, when placed on a high-fat diet, the transgenic
mice gained more body weight (Figure 4B) and accumulated
substantially more lipids in the brown fat (Figure 4C), although
they consumed a similar amount of food as controls (Figure 4D).
Thus, a modest overexpression of twist-1 in the adipose tissue
is sufficient to render the animals susceptible to high-fat-diet-
induced obesity. Indeed, the transgene decreased the expres-
sion of UCP1 and fatty acid oxidation genes in the brown fat
(Figure 4E). No gene expression difference was observed in
the white fat (Figure 4E), consistent with the fact that there is little
PGC-1a in this tissue. Next, we isolated brown fat tissue and
measured oxygen consumption ex vivo. The rate of oxygen
consumption was significantly lower in transgenic mice than in
the control littermates (Figure 4F). Electron microscopy also
revealed a clear reduction of mitochondria density in the brown
fat of transgenic mice (Figure 4G). Finally, we monitored their
body temperature when the mice were fed a high-fat diet.
Whereas no differences were observed during the day time,
the body temperature of the transgenic mice appeared to be
lower at night compared to their control littermates (Figure 4H),
probably reflecting an insufficiency of fat burning and heat
production in the brown fat. These results together pinpoint
a compromised brown fat function in the twist-1 transgenic
mice.78 Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc.Heterozygous Twist-1 Knockout Mice Have Increased
Brown Fat Metabolism and Are Obesity Resistant
We asked whether twist-1 is indispensable for the regulation of
energy homeostasis in vivo. Twist-1 homozygous knockout is
embryonically lethal. We thus compared the metabolic pheno-
type of twist-1 heterozygous mice and their body weight-
matched control littermates. When placed on a high-fat diet,
the knockout animals showed a remarkable obesity-resistant
phenotype (Figure 5A), accompanied by substantially less lipid
accumulation in the brown fat (Figure 5B) and yet similar food
consumption (Figure 5C). At the molecular level, expression of
UCP1 and oxidation genes in the brown fat, but not in the white
fat, was elevated (Figure 5D). As in the transgenic mice, the level
of PGC-1a in the brown fat of the knockout mice was not
significantly changed, consistent with the idea that the effects
of twist-1 are due to its direct modulation of PGC-1a activity,
not PGC-1a expression. Expression of liver genes important
for fatty acid oxidation or fatty acid and triglyceride synthesis
was also not affected (Figure 5E). Moreover, opposite to what
was observed in the transgenic mice, the brown fat of heterozy-
gous knockout mice displayed elevated oxygen consumption
(Figure 5F) and mitochondrial biogenesis (Figure 5G), and their
body temperature tended to be higher at night (Figure 5H). These
results suggest that the level of twist-1 in vivo is quantitatively
important for the control of energy homeostasis, providing
compelling in vivo evidence supporting our model that twist-1
is a critical negative regulator of PGC-1a-mediated mitochon-
drial metabolism and uncoupling in the brown fat.
Twist-1 Inhibits Histone H3 Acetylation on the
Promoters of PGC-1a Target Genes
We performed chromatin immunoprecipitation assays in brown
fat cells to determine the molecular basis by which twist-1
suppresses PGC-1a function. We focused on the UCP1
promoter, as thispromoter contains awell-definedPPAR-binding
site that may underlie the induction of UCP1 by PGC-1a (Collins
et al., 2004). Both PGC-1a and twist-1 at their endogenous levels
associated with the PPAR-binding site of the UCP1 promoter
(Figure 6A, and middle panel of Figure 6I). Importantly, twist-1’s
association was markedly decreased when PGC-1a was
knocked down by 40% (Figure 6B), supporting the notion
that twist-1 is recruited to the promoter by its interaction with
PGC-1a. Consistent with the PGC-1a target gene expression
data, expression of twist-1 suppressed PGC-1a-elicited Histone
H3 acetylation (Figure 6C). Similar results were obtained with the
carnitine palmitoyltransferase 1 (mCPT1) gene promoter (Figures
6D and S10). We found that twist-1 associated with the class II
Histone deacetylase HDAC5 (Figure 6E) and recruited HDAC5
to the promoters of UCP1 and mCPT1 (Figure 6F), which could
at least in part explain the loss of Histone H3 acetylation caused
by twist-1.
PPARd Mediates the Actions of PGC-1a and Twist-1
in Brown Fat Cells
To further understand the molecular framework of this PGC-1a-
twist-1 pathway, we sought to determine which transcription
factor mediates the effects of PGC-1a in the brown fat and
therefore could be linked to twist-1’s suppressive function. As
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Figure 4. Transgenic Expressing Twist-1 in Adipose Tissue Inhibits Brown Fat Metabolism
(A) Twist-1 transgene (TG) expression in the brown and white fat tissue.
(B) Net body weight gain in wild-type control littermates (WT) and transgenic (TG) mice after a 2-month high-fat diet (n = 7–12 mice per group). Their initial body
weights were similar, 16.65 ± 0.21 g (WT) versus 16.80 ± 0.43 g (TG) (p = 0.73).
(C) Representatives of brown fat histology after a 7-week high-fat diet.
(D) Consumption of high-fat diet (n = 5 mice per group).
(E) Gene expression in brown fat and white fat (n = 6 mice per group). **p < 0.01.
(F) Ex vivo oxygen consumption of brown fat (n = 4 mice per group).
(G) Mitochondrial density. Left, representative electron microscopy micrographs. Right panel, quantification from 12 micrographs of 4 mice per group.
M, mitochondria; L, lipid droplets.
(H) Body temperature was recorded in 10 min intervals (n = 8 mice per group). *p < 0.05.
Error bars represent standard error of the mean in all panels but (C).activation of PPARd promotes mitochondrial metabolism and
uncoupling (Wang et al., 2003), we considered PPARd as
a candidate. To genetically test this possibility, we first examined
whether there is a phenotypic overlap among loss of PPARd,PGC-1a acute knockdown, and twist-1 overexpression. We
knocked out the PPARd gene (floxed alleles) in brown fat cells
by cre recombinase adenovirus-mediated excision. Compared
to the cells that were infected by GFP control virus, theCell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc. 79
B C
0
0.5
1.0
1.5
2.0
2.5
3.0
F
oo
d 
in
ta
ke
 (g
/d
ay
)
WT KO
E
35.5
36.0
36.5
37.0
37.5
38.0
WT
KO
5pm 5am
B
od
y 
te
m
pe
ra
tu
re
(
c)
*
*
* * **
0
0.5
1.0
1.5
2.0
2.5
WT
KO
CP
T1
A
M
CA
D
Dg
at
1
G
pa
m
M
ttp
FA
S
AC
C1
Co
xI
I
Lipid
oxidation
Triglyceride/
lipoprotein
synthesis
Fatty acid
synthesis
F
WT KO WT KO
0
10
20
30
40
50
60
p=0.002
M
ito
ch
on
dr
ia
l d
en
si
ty
 (
%
)
H
D
UC
P-
1
M
CA
D
aP
2
M
CA
D
Brown fat tissue
aP
2
FA
S
Co
xI
I0
0.5
1.0
1.5
2.0
2.5
** **
**
*
White fat tissue
R
el
at
iv
e 
m
R
N
A
 le
ve
ls WT
KO
m
CP
T-
1
FA
S
PG
C-
1
G
WT
L
M
1µm
KO
M
L
A
N
et
 b
od
y 
w
ei
gh
t g
ai
n 
(g
)
week
0
3
6
9
12
15
18
21
0 1 2 3 4 5 6 7 8 9 10
*
**
**
**
**
**
**
*
WT
KO
WT KO
O
xy
ge
n 
co
ns
um
pt
io
n
(µ
lO
2/
m
g/
m
in
)
p=0.02
1
2
3
4
0
Figure 5. Increased Brown Fat Metabolism in Twist-1 Heterozygous Knockout Mice
(A) Body weight gain in wild-type control littermates (WT) and heterozygous knockout (KO) mice during a high-fat diet (n = 5–6 mice per group). *p < 0.02;
**p < 0.01. Their initial body weights were similar: 20.68 ± 2.09 g (WT) versus 19.60 ± 1.26 g (KO) (p = 0.47).
(B) Representative of brown fat histology after a 9-week high-fat diet. Note that more lipid accumulation is present in the control mice (C56BL6 background) in this
panel compared to the control mice (mixed background) in Figure 4C, probably due to a longer period of high-fat diet and/or genetic background.
(C) Consumption of a high-fat diet (n = 5–6 mice per group).
(D) Gene expressions in brown fat and white fat (n = 5–7 mice per group). *p < 0.05; **p < 0.01.
(E) Gene expression in liver (n = 5–6 mice per group).
(F) Ex vivo oxygen consumption of brown fat (n = 5 mice per group).
(G) Mitochondrial density. Left, representative electron microscopy micrographs. Right panel, quantification from 10 micrographs of 4 mice per group.
M, mitochondria; L, lipid droplets.
(H) Body temperature was recorded in 10 min intervals (n = 7–10 mice per group). *p < 0.05; **p < 0.01.
Error bars represent standard error of the mean in all panels but (B).PPARd-deficient cells (d/) displayed decreased expression of
mitochondrial metabolic genes (Figure 6G) but normal adipogen-
esis (Figure S11), a phenotype remarkably similar to those of
PGC-1a acute knockdown (Figures 3C and S12) and twist-1
overexpression (Figure 3G). In particular, loss of PPARd caused80 Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc.a dramatic reduction of UCP1 gene expression by more than
10-fold. The levels of PGC-1a, along with those of PPARg,
PPARa, and ERRa, which are also involved in mitochondrial
metabolism, remained unchanged (Figure 6G). This indicates
an essential, cell-autonomous requirement for PPARd in the
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Figure 7. Twist-1 Is Induced upon PPARd Activation in the Brown Fat
(A) Twist-1 expression in differentiated brown fat adipocytes treated with vehicle or PPAR agonists for 24 hr.
(B) PPAR associates with the twist-1 promoter.
(C) Twist-1 expression in the brown fat of C57BL6 mice treated with the PPAR agonists (n = 5 mice per group).
(D) Twist-1 expression in the brown fat of lean and obese mice (n = 3 mice per group).
(E) A coordinated transcriptional regulatory network in brown fat metabolism.
Error bars represent standard error of the mean in all panels but (E).expression of some, but not all, of the PGC-1a target genes. To
further test whether PPARd acts downstream of PGC-1a, we
measured UCP1 induction by the b3-adrenergic receptor
agonist in PPARd-deficient brown fat cells. The b3-adrenergic
receptor agonist stimulates UCP1 expression through increasing
both the activity and expression level of PGC-1a (Collins et al.,
2004). Although the PPARd-deficient cells had similar levels of
PGC-1a as the wild-type cells, they were almost completely
unresponsive to the agonist in the induction of UCP1
(Figure 6H). Indeed, in the absence of PPARd, PGC-1a was no
longer able to associate with the UCP1 promoter, which conse-
quently resulted in the loss of association of twist-1 with the
promoter (Figure 6I). Finally, we placed floxed PPARd mice
carrying the aP2-cre transgene at 4C for 6 hr. These animals’
ability to maintain their body temperature during the last hour
of the cold exposure was compromised compared to their
control littermates without aP2-cre (Figure 6J), further indicating82 Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc.a functional convergence of PPARd and PGC-1a. There was
30% of PPARd expression remaining in the brown fat of the
knockout mice (Figure 6J) (Barak et al., 2002); this might account
for the normal cold response during early time points. Together,
these lines of genetic and biochemical evidence suggest that
PPARd functions as a key mediator downstream of PGC-1a
and twist-1.
Twist-1 Is Induced by PPARd Activation in Brown Fat
We explored how twist-1 expression might be regulated. Treat-
ment of differentiated brown fat cells with the PPARd agonist, but
not the agonist for PPARg or PPARa, induced twist-1 expression
(Figure 7A). This induction was PPARd dependent, as the agonist
had no effect when the PPARd gene was deleted. Interestingly,
similar levels of twist-1 were observed in PPARd-deficient cells
relative to wild-type cells (Figure 7A); this pattern differs from
the target genes involved in metabolism described in
Figure 6G, indicating that PPARd is not required for the mainte-
nance of basal twist-1 expression. There are two probable
PPAR-binding sites in the twist-1 promoter, located in the
3.43 and 1.88 kb regions, respectively. In the basal condi-
tions, neither PPARd nor PPARg was associated with them.
Upon addition of their respective agonists, PPARd, but not
PPARg, was recruited to the distal site (Figure 7B), although
PPARg evidently associated with the PPAR-binding site in its
target gene aP2 promoter in the same experiments; these data
are consistent with the agonist-dependent regulation of twist-1
by PPARd. To determine whether activation of PPARd induces
twist-1 expression in animals, we analyzed tissue RNA samples
from wild-type C57BL6 mice treated with vehicle or the PPARd
agonist. The level of twist-1 in brown fat tissue was induced
2.8-fold by the agonist (Figure 7C). However, no significant
changes were observed in animals treated with agonists for
PPARg or PPARa (Figure 7C). Our data suggest that twist-1
serves as a negative-feedback regulatory loop to tightly modu-
late the PGC-1a/PPARd-controlled brown fat metabolism
(Figure 7E). Intriguingly, the twist-1 level was elevated in the
brown fat of obese mice (Figure 7D). This, coupled with
decreases of PGC-1a (Kakuma et al., 2000) and PPARd
(Figure S13) in these animals, may further aggravate the state
of obesity.
DISCUSSION
It has now become increasingly appreciated that brown fat
cells may play an important part in human energy homeostasis.
A better understanding of the molecular basis underlying its
unique metabolic property is obviously the first step in taking
full advantage of this cell type as a target for obesity and associ-
ated diseases. Whereas previous work has demonstrated
a central role for PGC-1a in governing brown fat metabolism,
the other factors involved and, in particular, how these potential
factors functionally and mechanistically interact and coordinate
with PGC-1a are poorly understood. Our results presented
here reveal a transcriptional network that provides insights into
this question. We demonstrate that twist-1 is physiologically crit-
ical in brown fat metabolism by directly antagonizing PGC-1a.
Moreover, twist-1 constitutes part of a feedback regulatory
loop in which the nuclear receptor PPARd not only acts down-
stream to mediate, at least in part, the function of PGC-1a, but
also controls twist-1 expression. Interestingly, this brown fat-
specific regulatory network appears to be exclusively involved
in energy dissipation, but not in fat cell formation.
Twist-1 is highly expressed at the embryonic stage and is
induced in cancer cells, consistent with its roles in early develop-
ment and tumor metastasis, respectively. Unexpectedly, at the
postnatal stage, twist-1 is mainly expressed in the adipose
tissue. Our studies performed both in vitro and in vivo elucidate
that twist-1 specifically regulates PGC-1a-controlled oxidative
metabolism and uncoupling in the brown fat. In particular,
adipose twist-1 transgenic mice and the heterozygous knockout
display completely opposite body weight gain and body temper-
ature profiles. These phenotypes can be largely explained by
their altered PGC-1a target gene expression profiles, oxygen
consumption, and mitochondrial biogenesis in the brown fat.Our results clearly establish twist-1 as a metabolic brake for
energy expenditure in the brown fat, and that its expression level
is critically important for the maintenance of whole-body energy
homeostasis. At present, the function of twist-1 in the white fat is
unclear. It is possible that twist-1 may regulate additional path-
ways related to adipocyte biology.
One question is how the interaction of twist-1 and PGC-1a
leads to suppression of PGC-1a function. Twist-1 neither desta-
bilizes PGC-1a nor perturbs its nuclear localization. We also
found no evidence that the interaction displaces PGC-1a from
its target gene promoters. Instead, twist-1 is recruited by PGC-
1a to the PGC-1a target gene promoters and thus exerts its
inhibitory function locally. This mode of action is clearly different
from the one employed in the suppression of Runx2 during bone
development; there, twist-1 blocks Runx2 association with the
target gene promoter through its interaction with the DNA-
binding domain of Runx2 (Bialek et al., 2004). Interestingly, the
regions of twist-1 that interact with PGC-1a and Runx2 appear
to be different, located in the N terminus and C terminus, respec-
tively; this further indicates a versatile nature of twist-1 in gene
regulation. The recruitment of twist-1 to PGC-1a target gene
promoters causes a dramatic decrease of Histone H3 acetyla-
tion, likely due to a subsequent recruitment of Histone deacety-
laseHDAC5. These results together outline aplausible underlying
mechanism by which twist-1 modulates brown fat metabolism.
Other potential mechanisms are also possible. For example,
twist-1 was shown to inhibit p300 acetyltransferase activity
in vitro (Hamamori et al., 1999). However, we were unable to
detect any association of p300 with the UCP1 promoter. Another
acetyltransferase, SRC-1, has been shown to regulate UCP1
expression (Picard et al., 2002). Indeed, we find that SRC-1 is
present on the UCP1 promoter, but this association is not
affected by twist-1 (unpublished data), consistent with the data
showing that these two proteins do not interact.
Our studies further uncovered PPARd as an integral compo-
nent in coordinating the actions of PGC-1a and twist-1 in brown
fat metabolism. The requirement for PPARd on expression of
PGC-1a target genes occurs in the context of normal expression
ofPPARg, PPARa, andERRa. Previouswork in other cell systems
suggests that the transcription factor YY1 and ERRa act down-
stream of PGC-1a in mitochondrial oxidative metabolism
(Cunningham et al., 2007; Mootha et al., 2004; Schreiber et al.,
2004). Those studies and ours presented here indicate that how
PGC-1a is mediated downstream is more complex, and is likely
to be cellular context dependent and/or promoter dependent.
Although by no means excluding the involvement of other tran-
scription factors, our genetic analyses suggest that in brown fat
cells PPARd is an important mediator, in particular for UCP1
expression. This idea is strengthened by our observation that
fat-specific PPARd knockoutmice are compromised inmaintain-
ingbody temperature during coldexposure. Furthermore,wefind
that PPARd, but not PPARa or PPARg, binds to the twist-1
promoter and directs twist-1 expression both in brown fat cell
culture and in whole animals, suggesting a feedback regulatory
mechanism. As PPARd is a lipid sensor that is activated by fatty
acids (Chawla et al., 2003), the transcriptional network described
here would presumably allow brown fat to respond to the body’s
nutrient status to ensure energy homeostasis.Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc. 83
In summary, our results provide important molecular insights
into how the PGC-1a-controlled energy expenditure pathway
is modulated and coordinated in the brown fat. Pharmacologi-
cally increasing PGC-1a activity and/or expression is considered
a therapeutic strategy for metabolic diseases (Baur et al., 2006;
Feige et al., 2008; Lagouge et al., 2006). Our data indicate that
a decreasing twist-1 level or disrupting its interaction with
PGC-1a may offer an alternative strategy.
EXPERIMENTAL PROCEDURES
Viruses
Adenoviruses for overexpression and knockdownwere generated by using the
AdEasy-1 system (He et al., 1998). The PGC-1a RNAi adenovirus construct
was kindly provided by Dr. Marc Montminy (Koo et al., 2004). All adenoviruses
were purified with cesium chloride ultracentrifugation, and virus titers were
determined in HEK 293 cells by scoring GFP-positive cells. Twist-1 RNAi
lentivirus constructs (Yang et al., 2004) were obtained from Addgene.
Adenovirus infection was performed in differentiated cells unless otherwise
indicated. GFP control adenovirus was added, if needed, to ensure a similar
degree of infection in different samples. Assays were performed 2 days after
infection.
Generation and Differentiation of Brown Fat Cells
Immortalized brown fat preadipocytes (df/f) were generated as described
(Tseng et al., 2004). We used mice containing floxed PPARd alleles (Barak
et al., 2002) that had been backcrossed with C57BL6 for nine generations.
Details are available in Supplemental Experimental Procedures.
Luciferase Reporter Assays, Coimmunoprecipitation,
and Chromatin Immunoprecipitation
Luciferase reporter assays, coimmunoprecipitation, and chromatin immuno-
precipitation are described in Supplemental Experimental Procedures.
Animals
The aP2 promoter-directed twist-1 transgenic mouse line was generated
in a SV129/C57BL6 mixed background and was backcrossed with C57BL6
for four generations. Heterozygous twist-1 knockout mice in a C57BL6 back-
ground were purchased from Jackson Laboratory, and cohorts were gener-
ated by crossing with wild-type C57BL6. Conditional PPARd floxed mice
(Barak et al., 2002) and aP2-Cre transgenic mice (He et al., 2003) were
described. Littermate controls were used in all of the experiments. A normal
diet containing 4% (w/w) fat was obtained from Harlan Teklad. A high-fat
diet containing 35% (w/w) fat content was obtained from Bioserv (Product
#F3282). Food consumption was measured daily for individually caged mice
for 2 weeks. The University of Massachusetts Medical School’s Institutional
Animal Care and Use Committee approved all of the animal studies.
Body Temperature
Mice were implanted with paraffin-coated iButtons (DS1922T-F5, Embedded
data systems) into their peritoneal cavities as described (Davidson et al., 2003).
Mice were allowed to recover for 2 weeks. Body temperature was then
recorded at a 10 min sampling interval. The data were retrieved with a data
reader.
Oxygen Consumption Assays
Brown fat was isolated and chopped into small pieces. Equal amounts (30 mg)
were used in 5 ml DPBS supplemented with 25 mM glucose, 1 mM pyruvate,
and 2% BSA. Respiration was measured with a Clark-type electrode (YSI
model 5300).
Experiments with PPAR Agonists
In brown fat adipocyte culture, differentiated cells were treated with vehicle,
PPARd agonist GW501516 (0.1 mM), or PPARg agonist rosiglitazone (1 mM)
for 24 hr. For in vivo experiments, total RNA samples from wild-type C57BL684 Cell 137, 73–86, April 3, 2009 ª2009 Elsevier Inc.mice treated with GW501516 were generated previously (Wang et al., 2004).
Wild-type C57BL6 mice were gavaged daily with rosiglitazone (30 mg/kg
per day), PPARa agonist GW7647 (3 mg/kg per day), or vehicle for 1 week.
Electron Microscopy
Details on electron microscopy are available in Supplemental Experimental
Procedures. We used ImageJ software to calculate mitochondrial area and
cellular area in individual micrographs, and mitochondrial density was ex-
pressed as a percentage of cellular area. In data presented in Figures 4G
and 5G, showing results of animal experiments, the area of the lipid droplet
was not included in the cellular area to avoid exaggerating the difference of
mitochondrial density.
Statistical Analysis
The Student’s t test (two-tailed) was used for statistical analysis. p < 0.05 was
considered significant. Data are presented as mean ± standard error of the
mean.
SUPPLEMENTAL DATA
SupplementalData includeSupplemental ExperimentalProcedures, 13 figures,
and 1 table and are available with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00136-6.
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